Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Phil Ambery
AstraZeneca, United Kingdom
Poster(s):
(257) Totality of Evidence Evaluating the Effectiveness of Repurposed Therapies for COVID19: What Can We Learn from Real-World Studies & Randomized Controlled Trials?
Saturday, August 27, 2022
8:00 AM – 6:00 PM
CEST
